<DOC>
	<DOCNO>NCT01279668</DOCNO>
	<brief_summary>Persistent cough common symptom , account 20 % referral outpatient chest clinic . Most cough cause self-limiting viral infection common cold . However , 1 4 people viral infection develop persistent cough , go several week . Whooping cough common cause persistent cough young people adult . Although whooping cough vaccine give lifelong protection severe infection , appear give long-term protection milder infection , make someone cough many week . There currently prove efficacious treatment persistent cough follow either viral infection infection whooping cough . Montelukast medication already license treatment asthma . It work block action chemical call leukotrienes , make airways people asthma inflame sensitive . There strong evidence suggest leukotrienes also involve cause persistent cough follow viral whooping cough infection . Montelukast may therefore also help settle persistent cough setting . Over 18 month , recruit patient age 16-49 year cough lasting 2-8 week general practice England . An oral fluid sample take participant test whooping cough . Participants randomly allocate receive 28-day course montelukast placebo tablet ask complete daily cough diary two week . They assess two week GP ( face-to-face ) four week another member practice clinical staff ( telephone ) . Some participant give 24-hour cough monitor wear study entry two-week follow-up . This study fund National Institute Health Research 's School Primary Care .</brief_summary>
	<brief_title>Montelukast Persistent Cough Young People Adults</brief_title>
	<detailed_description />
	<mesh_term>Cough</mesh_term>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Male Female , age 16 year 49 year inclusive . Presenting persistent cough 28 week ' duration without establish diagnosis ( e.g . asthma , gastrooesophageal reflux ) . Able complete cough diary study questionnaire . There contraindication montelukast . Chronic severe disease may cause persistent cough ( eg cystic fibrosis , bronchiectasis , cardiac failure ) . Immunodeficiency/immunocompromised state . Pregnancy . Breastfeeding . Current smoker ( i.e . stop smoke less 6 month ago ) . Regular medication associate persistent cough ( ACE inhibitor ) . The individual another clinical research study .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Montelukast</keyword>
	<keyword>Persistent cough</keyword>
	<keyword>Adults</keyword>
	<keyword>Double-blind randomise placebo control trial</keyword>
</DOC>